Literature DB >> 10590103

RNA dimerization defect in a Rous sarcoma virus matrix mutant.

L J Parent1, T M Cairns, J A Albert, C B Wilson, J W Wills, R C Craven.   

Abstract

The retrovirus matrix (MA) sequence of the Gag polyprotein has been shown to contain functions required for membrane targeting and binding during particle assembly and budding. Additional functions for MA have been proposed based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity even though they release particles of normal composition. Here we describe an RSV MA mutant with a surprising and previously unreported phenotype. In the mutant known as Myr1E, the small membrane-binding domain of the Src oncoprotein has been added as an N-terminal extension of Gag. While Myr1E is not infectious, full infectivity can be reestablished by a single amino acid substitution in the Src sequence (G2E), which eliminates the addition of myristic acid and the membrane-binding capacity of this foreign sequence. The presence of myristic acid at the N terminus of the Myr1E Gag protein does not explain its replication defect, because other myristylated derivatives of RSV Gag are fully infectious (e.g., Myr2 [C. R. Erdie and J. W. Wills, J. Virol. 64:5204-5208, 1990]). Biochemical analyses of Myr1E particles reveal that they contain wild-type levels of the Gag cleavage products, Env glycoproteins, and reverse transcriptase activity when measured on an exogenous template. Genomic RNA incorporation appears to be mildly reduced compared to the wild-type level. Unexpectedly, RNA isolated from Myr1E particles is monomeric when analyzed on nondenaturing Northern blots. Importantly, the insertional mutation does not lie within previously identified dimer linkage sites. In spite of the dimerization defect, the genomic RNA from Myr1E particles serves efficiently as a template for reverse transcription as measured by an endogenous reverse transcriptase assay. In marked contrast, after infection of avian cells, the products of reverse transcription are nearly undetectable. These findings might be explained either by the loss of a normal function of MA needed in the formation or stabilization of RNA dimers or by the interference in such events by the mutant MA molecules. It is possible that Myr1E viruses package a single copy of viral RNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590103      PMCID: PMC111525          DOI: 10.1128/jvi.74.1.164-172.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.

Authors:  R A Katz; R W Terry; A M Skalka
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.

Authors:  Y M Lee; X B Tang; L M Cimakasky; J E Hildreth; X F Yu
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.

Authors:  F R Cross; E A Garber; D Pellman; H Hanafusa
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

7.  Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein.

Authors:  J E Buss; M P Kamps; B M Sefton
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

9.  An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.

Authors:  D Pellman; E A Garber; F R Cross; H Hanafusa
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  32 in total

1.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Effects of Gag mutation and processing on retroviral dimeric RNA maturation.

Authors:  William Fu; Que Dang; Kunio Nagashima; Eric O Freed; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Intermolecular interactions between retroviral Gag proteins in the nucleus.

Authors:  Scott P Kenney; Timothy L Lochmann; Cullen L Schmid; Leslie J Parent
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

6.  Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.

Authors:  Robert A Dick; Elena Kamynina; Volker M Vogt
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

7.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

8.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 10.  Roles played by acidic lipids in HIV-1 Gag membrane binding.

Authors:  Balaji Olety; Akira Ono
Journal:  Virus Res       Date:  2014-07-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.